Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125244002 | 12524400 | 2 | F | 20160708 | 20160704 | 20160722 | EXP | US-AUROBINDO-AUR-APL-2016-08495 | AUROBINDO | MACCA AL. ALMOTRIPTAN/FLUOXETINE/ONDANSETRON INTERACTION. REACTIONS WEEKLY. 2016;1606:19 | 34.00 | YR | F | Y | 0.00000 | 20160722 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125244002 | 12524400 | 1 | PS | FLUOXETINE | FLUOXETINE HYDROCHLORIDE | 1 | Oral | 40 MG, DAILY | Y | U | 78619 | 40 | MG | ||||||
| 125244002 | 12524400 | 2 | I | FLUOXETINE | FLUOXETINE HYDROCHLORIDE | 1 | Y | U | 78619 | ||||||||||
| 125244002 | 12524400 | 3 | I | ONDANSETRON. | ONDANSETRON | 1 | Intravenous (not otherwise specified) | Y | U | 0 | INJECTION | ||||||||
| 125244002 | 12524400 | 4 | I | ONDANSETRON. | ONDANSETRON | 1 | Y | U | 0 | INJECTION | |||||||||
| 125244002 | 12524400 | 5 | I | ALMOTRIPTAN. | ALMOTRIPTAN | 1 | Oral | 12.5 MG, UNK | Y | U | 0 | 12.5 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125244002 | 12524400 | 1 | Anxiety |
| 125244002 | 12524400 | 2 | Depression |
| 125244002 | 12524400 | 3 | Nausea |
| 125244002 | 12524400 | 4 | Anxiety |
| 125244002 | 12524400 | 5 | Migraine |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125244002 | 12524400 | HO |
| 125244002 | 12524400 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125244002 | 12524400 | Agitation | |
| 125244002 | 12524400 | Chills | |
| 125244002 | 12524400 | Confusional state | |
| 125244002 | 12524400 | Coordination abnormal | |
| 125244002 | 12524400 | Drug interaction | |
| 125244002 | 12524400 | Nausea | |
| 125244002 | 12524400 | Pyrexia | |
| 125244002 | 12524400 | Serotonin syndrome | |
| 125244002 | 12524400 | Sluggishness | |
| 125244002 | 12524400 | Tremor | |
| 125244002 | 12524400 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |